140 related articles for article (PubMed ID: 25659052)
41. Microbiological evaluation of commercial probiotic products available in the USA in 2009.
Drago L; Rodighiero V; Celeste T; Rovetto L; De Vecchi E
J Chemother; 2010 Dec; 22(6):373-7. PubMed ID: 21303743
[TBL] [Abstract][Full Text] [Related]
42. Probiotic formulations and applications, the current probiotics market, and changes in the marketplace: a European perspective.
Saxelin M
Clin Infect Dis; 2008 Feb; 46 Suppl 2():S76-9; discussion S144-51. PubMed ID: 18181728
[TBL] [Abstract][Full Text] [Related]
43. Identification and characterization of starter lactic acid bacteria and probiotics from Columbian dairy products.
Perea Vélez M; Hermans K; Verhoeven TL; Lebeer SE; Vanderleyden J; De Keersmaecker SC
J Appl Microbiol; 2007 Sep; 103(3):666-74. PubMed ID: 17714400
[TBL] [Abstract][Full Text] [Related]
44. Probiotics: definition, sources, selection, and uses.
Sanders ME
Clin Infect Dis; 2008 Feb; 46 Suppl 2():S58-61; discussion S144-51. PubMed ID: 18181724
[TBL] [Abstract][Full Text] [Related]
45. Probiotics: from myth to reality. Demonstration of functionality in animal models of disease and in human clinical trials.
Dunne C; Murphy L; Flynn S; O'Mahony L; O'Halloran S; Feeney M; Morrissey D; Thornton G; Fitzgerald G; Daly C; Kiely B; Quigley EM; O'Sullivan GC; Shanahan F; Collins JK
Antonie Van Leeuwenhoek; 1999; 76(1-4):279-92. PubMed ID: 10532384
[TBL] [Abstract][Full Text] [Related]
46. Accuracy of species identity of commercial bacterial cultures intended for probiotic or nutritional use.
Huys G; Vancanneyt M; D'Haene K; Vankerckhoven V; Goossens H; Swings J
Res Microbiol; 2006 Nov; 157(9):803-10. PubMed ID: 16919915
[TBL] [Abstract][Full Text] [Related]
47. Probiotic and synbiotic safety in infants under two years of age.
van den Nieuwboer M; Claassen E; Morelli L; Guarner F; Brummer RJ
Benef Microbes; 2014 Mar; 5(1):45-60. PubMed ID: 24463207
[TBL] [Abstract][Full Text] [Related]
48. Market and product assessment of probiotic/prebiotic-containing functional foods and supplements manufactured in South Africa.
Brink M; Senekal M; Dicks LM
S Afr Med J; 2005 Feb; 95(2):114-9. PubMed ID: 15751206
[TBL] [Abstract][Full Text] [Related]
49. Challenges in translational research on probiotic lactobacilli: from in vitro assays to clinical trials.
Meijerink M; Mercenier A; Wells JM
Benef Microbes; 2013 Mar; 4(1):83-100. PubMed ID: 23434949
[TBL] [Abstract][Full Text] [Related]
50. Antimicrobial susceptibilities of Lactobacillus, Pediococcus and Lactococcus human isolates and cultures intended for probiotic or nutritional use.
Klare I; Konstabel C; Werner G; Huys G; Vankerckhoven V; Kahlmeter G; Hildebrandt B; Müller-Bertling S; Witte W; Goossens H
J Antimicrob Chemother; 2007 May; 59(5):900-12. PubMed ID: 17369278
[TBL] [Abstract][Full Text] [Related]
51. [Beneficial effects of consumption of a dairy product containing two probiotic strains, Lactobacillus coryniformis CECT5711 and Lactobacillus gasseri CECT5714 in healthy children].
Lara-Villoslada F; Sierra S; Boza J; Xaus J; Olivares M
Nutr Hosp; 2007; 22(4):496-502. PubMed ID: 17650892
[TBL] [Abstract][Full Text] [Related]
52. Sources, isolation, characterisation and evaluation of probiotics.
Fontana L; Bermudez-Brito M; Plaza-Diaz J; Muñoz-Quezada S; Gil A
Br J Nutr; 2013 Jan; 109 Suppl 2():S35-50. PubMed ID: 23360880
[TBL] [Abstract][Full Text] [Related]
53. Probiotics in fermented sausages.
Vuyst LD; Falony G; Leroy F
Meat Sci; 2008 Sep; 80(1):75-8. PubMed ID: 22063171
[TBL] [Abstract][Full Text] [Related]
54. Microbiologic evaluation of commercial probiotics.
Weese JS
J Am Vet Med Assoc; 2002 Mar; 220(6):794-7. PubMed ID: 11918274
[TBL] [Abstract][Full Text] [Related]
55. Probiotics, D-Lactic acidosis, oxidative stress and strain specificity.
Vitetta L; Coulson S; Thomsen M; Nguyen T; Hall S
Gut Microbes; 2017 Jul; 8(4):311-322. PubMed ID: 28080206
[TBL] [Abstract][Full Text] [Related]
56. Probiotic bacteria: legislative framework-- requirements to evidence basis.
Pineiro M; Stanton C
J Nutr; 2007 Mar; 137(3 Suppl 2):850S-3S. PubMed ID: 17311986
[TBL] [Abstract][Full Text] [Related]
57. Defining microbiota for developing new probiotics.
Collado MC; Bäuerl C; Pérez-Martínez G
Microb Ecol Health Dis; 2012; 23():. PubMed ID: 23990820
[TBL] [Abstract][Full Text] [Related]
58. Composition and Laboratory Correlation of Commercial Probiotics in India.
Kesavelu D; Rohit A; Karunasagar I; Karunasagar I
Cureus; 2020 Nov; 12(11):e11334. PubMed ID: 33173652
[TBL] [Abstract][Full Text] [Related]
59. Assessment of commercial probiotic bacterial contents and label accuracy.
Weese JS; Martin H
Can Vet J; 2011 Jan; 52(1):43-6. PubMed ID: 21461205
[TBL] [Abstract][Full Text] [Related]
60. Emerging pre-clinical safety assessments for potential probiotic strains: a review.
Haranahalli Nataraj B; Behare PV; Yadav H; Srivastava AK
Crit Rev Food Sci Nutr; 2023 Apr; ():1-29. PubMed ID: 37039078
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
